Clinical trial
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized…
NCT00364689 · University of Miami, Other · Terminated
Key facts
| NCT number | NCT00364689 |
|---|---|
| Title | RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial |
| Official title | RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial |
| Lead sponsor | University of Miami, Other |
| Collaborators | Bausch Health Americas, Inc. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatic Encephalopathy |
| Intervention type | Drug, Other |
| Interventions | Rifaximin, Lactulose, Placebo |
| Enrollment | 13 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Aug 16, 2006 |
| Last update posted | Sep 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: